Genpharmasec Board Approves Section 185 Loans and WTD Re-appointment
Genpharmasec Ltd 路 Outcome 路 02 Sept 2026, 9:19 pm
Genpharmasec Board Approves Section 185 Loans and WTD Re-appointment Genpharmasec Ltd's Board approved the re-appointment of Sohan Chaturvedi as Whole Time Director for a three-year term, effective 26th Apr'27. Crucially, the Board authorized advancing loans and providing guarantees or securities under Section 185 of the Companies Act, pending shareholder approval. The company scheduled its 34th AGM for 29th Sep'26 via video conferencing, establishing a book closure period from 23rd Sep'26 to 29th Sep'26. Additionally, the Board adopted the FY26 Annual Report and set 22nd Sep'26 as the cut-off date for AGM e-voting eligibility.
Original exchange filing (PDF)
More announcements from Genpharmasec Ltd
- Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th September, 2026. 路 03 Nov 2026
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. 路 03 Nov 2026
- Unaudited Standalone & consolidated Financial Result of the company for the quarter & half year ended 30th September 2026. 路 03 Nov 2026
- Outcome of the Meeting of Board of Directors held on Tuesday, 03rd November, 2026. 路 03 Nov 2026
- Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited .... 路 03 Nov 2026
- Intimation under regulation 30 - Change of name of Subsidiary of the company. 路 14 Oct 2026
- Disclosure of Voting Results and Scrutinizers report of the 34th Annual General Meeting held on 29th September, 2026. 路 30 Sept 2026
- Submission of Proceeding of the 34th Annual General Meeting of the Member of the Genpharmasec Ltd held on Tuesday, 29th September, 2026. 路 29 Sept 2026
